By Chris Wack AdaptHealth shares were up 27% to $9.68 after the company reported fourth-quarter revenue that beat analysts' expectations. The healthcare.
By Chris Wack Beam Therapeutics shares were up 31% to $47.02 after the company reported fourth-quarter earnings that beat analysts' expectations. The stock.
By Chris Wack Capricor Therapeutics shares were up 8%, to $4.29, after the biotechnology company said it has been granted an in-person Type-B meeting with.
By Chris Wack La Rosa Holdings shares more than doubled to $3.35 after the company bought a 100% interest in its La Rosa Realty Winter Garden franchisee,.